Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on ropivacaine.

R D Wang1, L A Dangler, R A Greengrass

  • 1Department of Anesthesiology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.

Expert Opinion on Pharmacotherapy
|February 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Influential factors for failure of enhanced recovery after surgery from hepatectomy for hepatocellular carcinoma and the establishment of risk prediction model].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2018
Same author

Paravertebral blocks reduce the risk of postoperative urinary retention in inguinal hernia repair.

Hernia : the journal of hernias and abdominal wall surgery·2018
Same author

Metal induced self-assembly of designed V-shape protein into 2D wavy supramolecular nanostructure.

Nanoscale·2015
Same author

Paravertebral blocks for analgesia following BM harvest.

Bone marrow transplantation·2011
Same author

Three-dimensional ultrasound-assisted popliteal catheter placement revealing aberrant anatomy: implications for block failure.

Acta anaesthesiologica Scandinavica·2008
Same author

[Protective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in mice].

Yao xue xue bao = Acta pharmaceutica Sinica·2003

Ropivacaine, a long-acting local anesthetic, offers improved cardiovascular safety and a wider margin of safety compared to bupivacaine. It provides differential sensory and motor block, with a lower risk of cardiotoxicity from accidental injection.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Long-acting local anesthetics are crucial for regional anesthesia and analgesia.
  • Bupivacaine has been a standard, but concerns exist regarding its cardiovascular safety.
  • Ropivacaine emerged as a newer agent with potential safety and efficacy advantages.

Purpose of the Study:

  • To compare the cardiovascular safety and efficacy of ropivacaine with bupivacaine.
  • To evaluate the differential sensory and motor block characteristics of ropivacaine.
  • To assess the risk of cardiotoxicity associated with ropivacaine in clinical practice.

Main Methods:

  • Review of post-marketing studies comparing bupivacaine and ropivacaine.
  • Analysis of animal toxicity studies on myocardial depression and arrhythmogenic potential.

Related Experiment Videos

  • Literature review on cardiotoxicity risks following inadvertent intravascular injection.

    • Main Results:

    • Ropivacaine demonstrates increased cardiovascular safety and a wider margin of safety than bupivacaine at equal doses.
    • Ropivacaine offers a greater differential sensory-motor block and a shorter elimination half-life, reducing accumulation potential.
    • Animal studies confirm ropivacaine's reduced cardiotoxicity, including less myocardial depression and lower arrhythmogenic potential.

    Conclusions:

    • Ropivacaine presents a favorable safety profile, particularly regarding cardiovascular toxicity, compared to bupivacaine.
    • Its distinct characteristics, including reduced cardiotoxicity, make it a safer option for regional anesthesia.
    • Ongoing studies are evaluating ropivacaine against levobupivacaine, another long-acting local anesthetic.